By G HossainPosted on December 22, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Jacobio discovered JAB-23E73, which is designed to treat several KRAS mutation subtypes, and is testing the therapy in multiple Phase I trials. AstraZeneca Finds Another Jewel in China With up to $2B For KRAS Inhibitor Post navigation BioSpace Editors’ Top 5 Biggest News Stories of the YearRadiopharma-Focused Aktis Squeezes in IPO to End Biotech Drought